S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Advocates Push Congress to Reauthorize ACT for ALS Before September Deadline

With the September 30 expiration of the landmark ACT for ALS law looming, over 20,100 Americans have signed a petition demanding immediate legislative renewal. Organized by the I AM ALS movement, the campaign highlights the critical need to preserve research infrastructure and life-extending therapy access for thousands of patients nationwide.

Advocates Push Congress to Reauthorize ACT for ALS Before September Deadline
Photo: Bio & News

The petition, gathered in just four days, underscores the urgency felt by a community facing a disease that strips away basic motor and respiratory functions. Supporters include public figures Katie Couric, Rebecca Gayheart Dane, and Tanea “Rebel” Brooks, all pressing for continuity in a program that has provided vital treatment pathways since its 2021 inception.

Legislators on the Senate HELP Committee and the House Energy and Commerce Committee face mounting pressure to prevent a lapse in funding and oversight. Advocates warn that any disruption to these programs would threaten the stability of current treatments that help patients manage symptoms. For those living with the disease, the legislative clock is not merely a bureaucratic hurdle but a matter of immediate survival.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!